1. Home
  2. AGRO vs KARD Comparison

AGRO vs KARD Comparison

Compare AGRO & KARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adecoagro S.A.

AGRO

Adecoagro S.A.

N/A

Current Price

$9.01

Market Cap

1.3B

ML Signal

N/A

Logo Kardigan Inc. Common Stock

KARD

Kardigan Inc. Common Stock

N/A

Current Price

$15.76

Market Cap

1.5B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AGRO
KARD
Founded
2002
2023
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2011
2026

Fundamental Metrics

Financial Performance
Metric
AGRO
KARD
Price
$9.01
$15.76
Analyst Decision
Hold
Strong Buy
Analyst Count
8
9
Target Price
$13.44
★ $41.13
AVG Volume (30 Days)
★ 524.0K
512.9K
Earning Date
11-11-2026
11-22-2026
Dividend Yield
★ 2.72%
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$56.28
N/A
Revenue Next Year
$5.47
$50.00
P/E Ratio
$37.52
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.89
$12.23
52 Week High
$15.89
$27.00

Technical Indicators

Market Signals
Indicator
AGRO
KARD
Relative Strength Index (RSI) 31.02 57.14
Support Level $8.92 $12.28
Resistance Level $10.09 $15.93
Average True Range (ATR) 0.31 1.14
MACD -0.05 0.35
Stochastic Oscillator 7.69 78.38

Price Performance

Historical Comparison
AGRO
KARD

About AGRO Adecoagro S.A.

Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The group operates in two lines of business, namely, Farming and Sugar, Ethanol and Energy. The Farming is further comprised of three reportable segments: Crops, Rice and Dairy. Sugar, Ethanol and Energy Segment, consists of cultivating sugarcane, which is processed in owned sugar mills, transformed into ethanol, sugar and electricity, in addition to biomethane and then marketed.

About KARD Kardigan Inc. Common Stock

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.

Share on Social Networks: